Comparison of Top Two Shares of the Day: Helmerich & Payne, Inc. (NYSE:HP), Celgene Corporation (NASDAQ:CELG)

Helmerich & Payne, Inc. (NYSE:HP)

Helmerich & Payne, Inc. (NYSE:HP) closed at $39.17 on the last trading session with an decrease of -0.61%, whereas, it previously closed at $39.41. The company has a market capitalization of $4.41 Billion. The company traded shares of 1.23 Million on the trading day while its three month average volume stands at 1.43 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Helmerich & Payne, Inc. (NYSE:HP) produced diluted EPS of -0.78. The EPS estimate for next year as estimated by analysts is at 1.33 while EPS for next quarter is estimated at 0.27. Earnings per Share growth for this year is reported at 89.7, while the analysts estimated the EPS growth for next year at 1.33% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -15.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Helmerich & Payne, Inc. (NYSE:HP) is at 0 while the forward p/e is at 29.56. The P/S or Price to Sales ratio of Helmerich & Payne, Inc. (NYSE:HP) stands at 1.55 and Price to Book or P/B for the most recent quarter stands at 1.05. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Helmerich & Payne, Inc. (NYSE:HP) are reported at 2.5 and 2.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Helmerich & Payne, Inc. (NYSE:HP) stands at -1.2, -1.7 and 0.1 respectively

The trailing twelve month Revenue of Helmerich & Payne, Inc. (NYSE:HP) is reported at 2.85 Billion with income of -85400000. The outstanding shares of Helmerich & Payne, Inc. (NYSE:HP) are 112.64 Million. The institutional Ownership of the shares of 98.4 stands at 0.80%, this figure is decreased -1.11 in the last six months. The insider ownership for the shares of Helmerich & Payne, Inc. (NYSE:HP) is ticked at 0.1%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Helmerich & Payne, Inc. (NYSE:HP) is the Mean Target Price estimated by the analysts which stands at 54.52. The 52 week high of Helmerich & Payne, Inc. (NYSE:HP) is placed at 73.74 and 52 week low is standing at 39.07.

Performance wise the shares of Helmerich & Payne, Inc. (NYSE:HP) fell down -10.9% for the week, it also fell -21.72% for the monthly performance, while for the quarter it went up -32.56%. The shares decrease -31.26% for the half year and plummeted for the Year-To-Date performance. The shares of Helmerich & Payne, Inc. (NYSE:HP) shrinked -38.37% for the yearly performance.

Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (NASDAQ:CELG) closed at $93.31 on the last trading session with an increase of 0.45%, whereas, it previously closed at $92.89. The company has a market capitalization of $66.24 Billion. The company traded shares of 2.39 Million on the trading day while its three month average volume stands at 4.29 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Celgene Corporation (NASDAQ:CELG) produced diluted EPS of 7.25. The EPS estimate for next year as estimated by analysts is at 12.3 while EPS for next quarter is estimated at 2.69. Earnings per Share growth for this year is reported at 4.8, while the analysts estimated the EPS growth for next year at 12.3% and Earnings growth for next 5 years stands at 14.7% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 26.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Celgene Corporation (NASDAQ:CELG) is at 12.87 while the forward p/e is at 7.58. The P/S or Price to Sales ratio of Celgene Corporation (NASDAQ:CELG) stands at 4.05 and Price to Book or P/B for the most recent quarter stands at 6.56. The Price to Free Cash Flow ratio or P/FCF is reported at 8.69. The quick ratio and the current ratio of Celgene Corporation (NASDAQ:CELG) are reported at 3.3 and 3.4 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Celgene Corporation (NASDAQ:CELG) stands at 14.4, 72.1 and 16.5 respectively

The trailing twelve month Revenue of Celgene Corporation (NASDAQ:CELG) is reported at 16.35 Billion with income of 5.23 Billion. The outstanding shares of Celgene Corporation (NASDAQ:CELG) are 709.86 Million. The institutional Ownership of the shares of 78.1 stands at 0.80%, this figure is decreased -0.27 in the last six months. The insider ownership for the shares of Celgene Corporation (NASDAQ:CELG) is ticked at 0.1%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Celgene Corporation (NASDAQ:CELG) is the Mean Target Price estimated by the analysts which stands at 97. The 52 week high of Celgene Corporation (NASDAQ:CELG) is placed at 98.97 and 52 week low is standing at 58.59.

Performance wise the shares of Celgene Corporation (NASDAQ:CELG) fell down -2.08% for the week, it also rise 2.69% for the monthly performance, while for the quarter it went up -2.3%. The shares increase 2.9% for the half year and flew up for the Year-To-Date performance. The shares of Celgene Corporation (NASDAQ:CELG) grew 0.65% for the yearly performance.

You may missed